Grant Masson

817 total citations
12 papers, 606 citations indexed

About

Grant Masson is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Grant Masson has authored 12 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Grant Masson's work include Mitochondrial Function and Pathology (4 papers), Adipose Tissue and Metabolism (4 papers) and Cardiac Ischemia and Reperfusion (3 papers). Grant Masson is often cited by papers focused on Mitochondrial Function and Pathology (4 papers), Adipose Tissue and Metabolism (4 papers) and Cardiac Ischemia and Reperfusion (3 papers). Grant Masson collaborates with scholars based in Canada, United States and Poland. Grant Masson's co-authors include Jason R.B. Dyck, Nikole J. Byrne, Miranda M. Sung, Jamie Boisvenue, Carrie-Lynn M. Soltys, Jody Levasseur, Ty T. Kim, Donna L. Beker, Nirmal Parajuli and Shereen M. Hamza and has published in prestigious journals such as Circulation Research, Diabetes and The FASEB Journal.

In The Last Decade

Grant Masson

12 papers receiving 603 citations

Peers

Grant Masson
Ty T. Kim Canada
Haitao Xiao China
Ildefonso Roldán Torres Spain
Essi Martonen Finland
Marlies de Ligt Netherlands
Nikole J. Byrne Canada
Jiangying Kuang China
Xue-Fen Pang China
Dafa Ding China
Elizabeth Carreón‐Torres Mexico
Ty T. Kim Canada
Grant Masson
Citations per year, relative to Grant Masson Grant Masson (= 1×) peers Ty T. Kim

Countries citing papers authored by Grant Masson

Since Specialization
Citations

This map shows the geographic impact of Grant Masson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grant Masson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grant Masson more than expected).

Fields of papers citing papers by Grant Masson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grant Masson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grant Masson. The network helps show where Grant Masson may publish in the future.

Co-authorship network of co-authors of Grant Masson

This figure shows the co-authorship network connecting the top 25 collaborators of Grant Masson. A scholar is included among the top collaborators of Grant Masson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grant Masson. Grant Masson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Matsumura, Nobutoshi, Shingo Takahara, Zaid H. Maayah, et al.. (2018). Resveratrol improves cardiac function and exercise performance in MI-induced heart failure through the inhibition of cardiotoxic HETE metabolites. Journal of Molecular and Cellular Cardiology. 125. 162–173. 39 indexed citations
2.
Matsumura, Nobutoshi, Ian M. Robertson, Shereen M. Hamza, et al.. (2017). A novel complex I inhibitor protects against hypertension-induced left ventricular hypertrophy. American Journal of Physiology-Heart and Circulatory Physiology. 312(3). H561–H570. 15 indexed citations
3.
Byrne, Nikole J., Nirmal Parajuli, Jody Levasseur, et al.. (2017). Empagliflozin Prevents Worsening of Cardiac Function in an Experimental Model of Pressure Overload-Induced Heart Failure. JACC Basic to Translational Science. 2(4). 347–354. 129 indexed citations
4.
Sung, Miranda M., Nikole J. Byrne, Ty T. Kim, et al.. (2017). Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 312(3). H552–H560. 41 indexed citations
5.
Byrne, Nikole J., Jody Levasseur, Miranda M. Sung, et al.. (2016). Normalization of cardiac substrate utilization and left ventricular hypertrophy precede functional recovery in heart failure regression. Cardiovascular Research. 110(2). 249–257. 30 indexed citations
6.
Sung, Miranda M., Ty T. Kim, Emmanuel Denou, et al.. (2016). Improved Glucose Homeostasis in Obese Mice Treated With Resveratrol Is Associated With Alterations in the Gut Microbiome. Diabetes. 66(2). 418–425. 180 indexed citations
7.
Sung, Miranda M., Nikole J. Byrne, Jody Levasseur, et al.. (2015). Cardiomyocyte‐Specific Ablation of the Long‐Chain Fatty Acid Transporter CD36 Accelerates the Progression of Pressure Overload‐Induced Heart Failure in Mice. The FASEB Journal. 29(S1). 1 indexed citations
8.
Zordoky, Beshay N., Jeevan Nagendran, Thomas Pulinilkunnil, et al.. (2014). AMPK-Dependent Inhibitory Phosphorylation of ACC Is Not Essential for Maintaining Myocardial Fatty Acid Oxidation. Circulation Research. 115(5). 518–524. 44 indexed citations
9.
Sung, Miranda M., Subhash K. Das, Jody Levasseur, et al.. (2014). Resveratrol Treatment of Mice With Pressure-Overload–Induced Heart Failure Improves Diastolic Function and Cardiac Energy Metabolism. Circulation Heart Failure. 8(1). 128–137. 81 indexed citations
10.
McLean, Brent A., Petra C. Kienesberger, Wang Wang, et al.. (2012). Enhanced recovery from ischemia–reperfusion injury in PI3Kα dominant negative hearts: Investigating the role of alternate PI3K isoforms, increased glucose oxidation and MAPK signaling. Journal of Molecular and Cellular Cardiology. 54. 9–18. 15 indexed citations
11.
Sung, Miranda M., Carrie-Lynn M. Soltys, Grant Masson, Jamie Boisvenue, & Jason R.B. Dyck. (2010). Improved cardiac metabolism and activation of the RISK pathway contributes to improved post-ischemic recovery in calorie restricted mice. Journal of Molecular Medicine. 89(3). 291–302. 23 indexed citations
12.
Folmes, Clifford D.L., Grzegorz Sawicki, Virgilio J. J. Cadete, et al.. (2010). Novel O-palmitolylated beta-E1 subunit of pyruvate dehydrogenase is phosphorylated during ischemia/reperfusion injury. Proteome Science. 8(1). 38–38. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ty T. Kim Breakdown of academic impact, for papers by Haitao Xiao Breakdown of academic impact, for papers by Ildefonso Roldán Torres Breakdown of academic impact, for papers by Essi Martonen Breakdown of academic impact, for papers by Marlies de Ligt Breakdown of academic impact, for papers by Nikole J. Byrne Breakdown of academic impact, for papers by Jiangying Kuang Breakdown of academic impact, for papers by Xue-Fen Pang Breakdown of academic impact, for papers by Dafa Ding Breakdown of academic impact, for papers by Elizabeth Carreón‐Torres
Rankless by CCL
2026